Sienna Biopharmaceuticals, Inc.
SNNAQ · OTC
12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$73 | -$51 | -$21 | -$11 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $2 | $0 | $0 |
| Change in WC | $3 | $1 | $2 | $0 |
| Other Non-Cash | $4 | $6 | $1 | $1 |
| Operating Cash Flow | -$62 | -$41 | -$18 | -$10 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | -$7 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$7 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $30 | $4 | $0 | -$1 |
| Stock Issued | $6 | $67 | $1 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$3 |
| Dividends Paid | $0 | $0 | $0 | -$45 |
| Other Fin. Act. | $0 | $36 | $28 | $19 |
| Financing Cash Flow | $36 | $107 | $29 | $15 |
| Forex Effect | -$0 | -$0 | $0 | $0 |
| Net Chg. in Cash | -$26 | $65 | $4 | $5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $75 | $9 | $5 | $0 |
| End Cash | $49 | $74 | $9 | $5 |
| Free Cash Flow | -$62 | -$41 | -$18 | -$10 |